Adagio Therapeutics racks up $50m Series A
Waltham, Massachusetts-based Adagio Therapeutics Inc, a developer of antibodies for coronaviruses, has raised $50 million in Series A financing.
17 July 2020•1 min read
Waltham, Massachusetts-based Adagio Therapeutics Inc, a developer of antibodies for coronaviruses, has raised $50 million in Series A financing.
San Joaquin County to slow venture commitments
15 October 2026 · 2 mins read
DOWNLOAD: Fundraising holds steady in Q3
14 October 2026 · 2 mins read
Why Endeavor Catalyst is betting big on Southeast Asia
8 October 2026 · 4 mins read
Dig's new fund bets on infrastructure built around foundation models
6 October 2026 · 4 mins read
Meet venture capital’s 2026 Women of Influence
5 October 2026 · 4 mins read
Eyeing opportunities and how the Women of Influence see trends developing
5 October 2026 · 3 mins read
Pulse Fund backer impressed with founder's 'relentless' dedication to climate
30 September 2026 · 5 mins read
